Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.

Abstract

INTRODUCTION The combined impact of advances in diagnosis and treatment of stage I NSCLC has not been assessed comprehensively. To define the survival impact of modern staging and treatment techniques for clinical stage I NSCLC, the Veterans Administration Central Cancer Registry, a database of U.S. veterans in whom the disease was diagnosed in the Veteran… (More)
DOI: 10.1016/j.jtho.2017.09.1952

Topics

Cite this paper

@article{Boyer2017ImprovedSO, title={Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.}, author={Matthew J. Boyer and Christina D. Williams and David H. Harpole and Mark W. Onaitis and Michael J. Kelley and Joseph Kamel Salama}, journal={Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer}, year={2017}, volume={12 12}, pages={1814-1823} }